ctDNA Methylation Sequencing for Myeloma

Clinical trial NCT05578625 · UNKNOWN

Trial details

NCT number: NCT05578625
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2022-08-31
Primary completion: 2023-08-31
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.